Weekly Newsletter   Challenge account   Weekly Newsletter   


Posts Tagged With 'biotech'

Regenerative Medicine Company Faces NASDAQ Delisting

After being given roughly a month to show that it had gotten its financials in order, Osiris Therapeutics (NASDAQ: OSIR) has failed and faces a real chance of being delisted. On Monday, the company provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ. In March, Osiris received a Continue reading →

Whatever Their Q1 2016 Earnigns, Biotech/Biopharma Companies Are Strong Long-Term Plays

We’re into our third week of Q1 2016 earnings reports, and we have seen sectors we thought would horribly disappoint, beat estimates, while those that many thought would beat with flying colors, disappointed. Up this week to report their most recent earnings are several biotech and biopharma companies. Despite the volatility in the spaces, I Continue reading →